Four years after the launch of Article 51, more than 1,000 projects have been submitted. Among them, 118 experiments have been authorized, enabling the treatment of one million patients throughout France. These experiments are very diverse and cover many of the issues facing our healthcare system.
View Article and Find Full Text PDFWhile the need to test new ways of organizing our healthcare system has long been recognized, successive initiatives have not always been up to the challenge. Drawing lessons from past experiences, as well as foreign examples, Article 51 of the Social Security Financing Act for 2018 created a new framework for innovative health experiments. Actors in the field now have the opportunity to develop innovative projects while relying on a support and evaluation system for the duration of their trials, according to a logic of co-construction between all stakeholders.
View Article and Find Full Text PDFA nine months old girl with prenatal diagnosis of bilateral hydronephrosis underwent serious studies and in view of the presumed diagnosis of right functional annulment, a right laparoscopic nephroureterectomy was performed. The anatomopatological result was suggestive of tuberculosis without previous contact with the disease. Postoperatively, the child received antituberculosis therapy (ATT) for a full 8 months (isoniazid, rifampin, pyrazinamide and ethambutol for 2 months and isoniazid and rifampin for 6 months) and the follow-up tests revealed improvement of ureterohydronephrosis in left kidney.
View Article and Find Full Text PDF